Previous 10 | Next 10 |
home / stock / knbif / knbif news
Kane Biotech ( OTCPK:KNBIF ): Q3 GAAP EPS of -$0.01. More news on: Kane Biotech Inc., Earnings news and commentary, Consumer stocks news, , Read more ...
Kane Biotech ( OTCPK:KNBIF ): Q2 GAAP EPS of C$0.02. More news on: Kane Biotech Inc., Earnings news and commentary, Consumer stocks news, , Read more ...
Kane Biotech ( OTCPK:KNBIF ): Q1 GAAP EPS of -C$0.008. More news on: Kane Biotech Inc., Earnings news and commentary, Consumer stocks news, , Read more ...
WINNIPEG, Manitoba, April 17, 2019 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE), (the “Corporation” or “Kane Biotech”), a biotechnology company engaged in the research, development and commercialization of technologies and products that prevent and remove mi...
Kane Biotech ( OTCPK:KNBIF ): Q4 GAAP EPS of -C$0.008. More news on: Kane Biotech Inc., Earnings news and commentary, Consumer stocks news, , Read more ...
WINNIPEG, Manitoba, March 25, 2019 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE), (the “Corporation” or “Kane Biotech”), a biotechnology company engaged in the research, development and commercialization of technologies and products that prevent and remove mi...
WINNIPEG, Manitoba, March 20, 2019 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE), (the “Corporation” or “Kane Biotech”), is pleased to announce today that it will host a conference call and webcast on Tuesday, March 26, 2019 at 4:00pm Eastern Time to dis...
WINNIPEG, Manitoba, Feb. 19, 2019 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE), (the “Corporation” or “Kane Biotech”), is pleased to announce that it has signed a non-exclusive Distribution Agreement with a major Chinese distributor and secured its first ord...
WINNIPEG, Manitoba, Feb. 04, 2019 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE), (the “Corporation” or “Kane Biotech”), is pleased to announce that the U.S. District Court of Eastern Missouri that is overseeing the lawsuit filed by Kane Biotech against Nestec...
WINNIPEG, Manitoba, Jan. 30, 2019 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE, OTCQB:KNBIF), (the “Corporation” or “Kane Biotech”), is pleased to announce that it has secured an additional purchase order for bluestem™ products, from the North American...
News, Short Squeeze, Breakout and More Instantly...
WINNIPEG, Manitoba, July 23, 2024 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (“Kane Biotech”, “Kane” or the “Company”) announces that the US Food and Drug Administration (FDA) has eliminated its usage limitation on the Company’...
WINNIPEG, Manitoba, July 17, 2024 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE; OTCQB:KNBIF) (“Kane Biotech” or “Kane”) announces that it has received ISO 13485:2016 Medical Device Single Audit Program (“MDSAP”) Quality Certification as a designer, de...
WINNIPEG, Manitoba, July 11, 2024 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (“Kane Biotech” or “Kane”) announces that it has signed a worldwide license agreement with Arizona-based Omni Bioceutical Innovations Inc. (“Omni”) for its c...